ArticleGMS infectious diseases2019

Potential savings through single-dose intravenous Dalbavancin in long-term MRSA infection treatment - a health economic analysis using German DRG data.

Michael Wilke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.